MECHANISM OF HIPPOCAMPAL CD95/CD95L AND BDNF/TRKB PATHWAY IN THE DEVELOPMENT OF TRIGEMINAL NEURALGIA IN RATS

被引:1
|
作者
Deng, Ruyun [1 ]
机构
[1] Daqing Oilfield Gen Hosp, Dept Anesthesia Surg, Daqing 163000, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2022年 / 38卷 / 03期
关键词
Hippocampus; CD95; CD95L pathway; BDNF; TrkB pathway; trigeminal neuralgia; mechanism;
D O I
10.19193/0393-6384_2022_3_328
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study aims to explore the mechanism of hippocampal apoptotic factor CD95 and its ligand (CD95L) pathway, as well as brain-derived neurotrophic factor (BDNF) and its receptor tyrosine kinase B (TrkB) pathway, in the development of trigeminal neuralgia in rats. Methods: Forty healthy adult male SD rats were randomly divided into control and model groups. The model group was used to establish the trigeminal neuralgia model, while the control group was exposed to the infraorbital nerve without ligation. The mechanical pain domain was measured before the operation, 5 days after the operation, 15 days after the operation, and 30 days after the operation. The learning and memory function of rats was evaluated by a water maze test 30 days after modeling. The relative expression levels of interleukin-113 (IL-1 13), Caspase-3, BDNF, TrkB, CD95, and CD95L were detected by Western blot. Results: There was no significant difference in mechanical pain area between the two groups before operation (P 0.05). The mechanical pain area of the model group was significantly lower than that of the control group at 5, 15, and 30 days after the operation (P<0.05). The escape latency level of the model group was significantly higher than that of the control group (P<0.05). The times of crossing the platform and the percentage of time in the target quadrant in the model group were significantly lower than those in the control group (P<0.05). IL-1 in model group 13 The protein levels of Caspase-3 and Caspase-3 in the treatment group were significantly higher than those in the control group (P<0.05). The protein levels of BDNF and TrkB in the model group were significantly lower than those in the control group (P<0.05). The protein levels of CD95 and CD95L in the model group were significantly higher than those in the control group (P<0.05). Conclusion: Hippocampal CD95/CD95L and BDNF/TrkB pathways mediate the trigeminal neuralgia occurrence and development in rats by regulating neuroinflammation and neuronal apoptosis and even leading to cognitive impairment in rats.
引用
收藏
页码:2147 / 2151
页数:5
相关论文
共 50 条
  • [21] CD95 is unmutated in cultivated H-RS cells resistant to apoptosis via CD95/CD95L interaction.
    Re, D
    Hofmann, A
    Wolf, J
    Diehl, V
    Jox, A
    BLOOD, 1998, 92 (10) : 189B - 189B
  • [22] Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
    Risso, Vesna
    Lafont, Elodie
    Le Gallo, Matthieu
    CELL DEATH & DISEASE, 2022, 13 (03)
  • [23] Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
    Vesna Risso
    Elodie Lafont
    Matthieu Le Gallo
    Cell Death & Disease, 13
  • [24] Characterization of CD95 ligand (CD95L)-induced apoptosis in human tenon fibroblasts
    Hueber, A
    Welsandt, G
    Jordan, JF
    Mietz, H
    Weller, M
    Krieglstein, GK
    Esser, PJ
    EXPERIMENTAL EYE RESEARCH, 2002, 75 (01) : 1 - 8
  • [25] Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L
    Sigel, JE
    Hsi, ED
    MODERN PATHOLOGY, 2000, 13 (04) : 446 - 451
  • [26] Effect of the CD14/TLR4 pathway on glioblastoma cell proliferation induced by CD95/CD95L pathway activation
    Sarrazy, V.
    Billet, F.
    Jauberteau, M. O.
    Desmouliere, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 78 - 78
  • [27] CD95L/CD95 GENE DELETION DECREASES MOUSE GLIOMA TUMORIGENESIS THROUGH THE INHIBITION OF NON-CANONICAL CD95L/CD95-MEDIATED CELL GROWTH AND IMMUNOSUPPRESSION
    Quijano-Rubio, Clara
    Weller, Michael
    NEURO-ONCOLOGY, 2021, 23 : 37 - 38
  • [28] Carboxy-terminal domain of CD95 suppresses anti-CD95 antibody mediated but not CD95L mediated
    Thilenius, ARB
    Russell, JH
    FASEB JOURNAL, 1996, 10 (06): : 408 - 408
  • [29] CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract:: fictions and facts
    Sträter, J
    Möller, P
    VIRCHOWS ARCHIV, 2003, 442 (03) : 218 - 225
  • [30] Upregulation of Fas-FasL (CD95/CD95L)-mediated epithelial apoptosis in pouchitis
    Bennett, MW
    Coffey, JC
    Wang, JH
    Neary, P
    O'Connell, J
    Shanahan, F
    Redmond, HP
    Kirwan, WO
    GASTROENTEROLOGY, 2001, 120 (05) : A185 - A185